Trials / Completed
CompletedNCT02517281
Prospective Clinical and Biologic Study of Secondary Cutaneous Effects in Targeted Cancer Therapies
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 141 (actual)
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to do a descriptive analysis of the cutaneous toxicity observed in patients treated using targeted therapies in order to have a better understanding of the skin pathophysiology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Biopsy |
Timeline
- Start date
- 2011-07-12
- Primary completion
- 2022-06-22
- Completion
- 2022-06-22
- First posted
- 2015-08-07
- Last updated
- 2026-03-20
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02517281. Inclusion in this directory is not an endorsement.